Tag: clean steam

Pre-Use Post-Sterilization Integrity Testing (PUPSIT): Practical Implementation Practical Implementation of Pre-Use Post-Sterilization Integrity Testing (PUPSIT) in Pharmaceutical Manufacturing Pre-Use Post-Sterilization Integrity Testing (PUPSIT) represents a critical control point in sterility assurance within pharmaceutical manufacturing environments. It bridges the gap between sterilization processes and subsequent aseptic operations by confirming that sterilizing-grade filters or sterilization barriers maintain…

Read More “Pre-Use Post-Sterilization Integrity Testing (PUPSIT): Practical Implementation” »

Filter Integrity Test Failures: Investigation Strategy and Batch Impact Assessment Managing Filter Integrity Test Failures in Sterility Assurance: Step-by-Step Investigation and Batch Impact Assessment Maintaining impeccable sterility assurance in pharmaceutical manufacturing is paramount to product quality and patient safety. A critical component of this assurance is the proper functioning and validation of sterilizing filters—widely used…

Read More “Filter Integrity Test Failures: Investigation Strategy and Batch Impact Assessment” »

Filter Integrity Test Failures: Investigation Strategy and Batch Impact Assessment Comprehensive Guide to Filter Integrity Test Failures: Investigation and Batch Impact Assessment In pharmaceutical manufacturing, sterility assurance plays a crucial role in ensuring product safety and regulatory compliance. Integrity testing of sterilizing filters is a critical control point within aseptic processing and GMP utilities such…

Read More “Filter Integrity Test Failures: Investigation Strategy and Batch Impact Assessment” »

Terminal Sterilization: Overkill vs Bioburden-Based Approaches Terminal Sterilization: Understanding Overkill and Bioburden-Based Strategies in Pharmaceutical Manufacturing Ensuring sterility assurance is fundamental for pharmaceutical manufacturers engaged in sterile product fabrication. Both the United States Food and Drug Administration (FDA) and European Medicines Agency (EMA), among other global regulatory bodies, emphasize validated and robust sterilization processes aligned…

Read More “Terminal Sterilization: Overkill vs Bioburden-Based Approaches” »

Terminal Sterilization: Overkill vs Bioburden-Based Approaches Terminal Sterilization in Pharmaceutical Manufacturing: Overkill and Bioburden-Based Methodologies Terminal sterilization remains a cornerstone of pharmaceutical manufacturing, critical for ensuring product sterility assurance and patient safety. This step-by-step tutorial offers an in-depth exploration of terminal sterilization strategies, focusing on overkill and bioburden-based approaches. It targets pharmaceutical professionals involved in…

Read More “Terminal Sterilization: Overkill vs Bioburden-Based Approaches” »

Sterility Assurance Level (SAL): What 10⁻⁶ Really Means in GMP Practice Sterility Assurance Level (SAL): Understanding and Applying 10⁻⁶ in Pharmaceutical GMP Practice The concept of sterility assurance is central to the production and control of sterile pharmaceutical products, especially in compliance with Good Manufacturing Practice (GMP) requirements. This tutorial will provide a comprehensive, step-by-step…

Read More “Sterility Assurance Level (SAL): What 10⁻⁶ Really Means in GMP Practice” »

How to Design an Aseptic Process to Achieve Required Sterility Assurance Step-by-Step Guide to Designing an Aseptic Process for Achieving Sterility Assurance The manufacture of sterile pharmaceutical products requires stringent control to assure sterility assurance throughout the process. Designing an aseptic process involves an integrated approach that combines principles of pharma microbiology, GMP utilities, aseptic…

Read More “How to Design an Aseptic Process to Achieve Required Sterility Assurance” »

Aseptic Process Simulation (Media Fill): Design, Execution and Interpretation Aseptic Process Simulation (Media Fill): A Step-by-Step Guide for Pharma Sterility Assurance Aseptic process simulation, commonly known as media fill, is a cornerstone of sterility assurance in pharmaceutical manufacturing. It is a critical validation activity designed to simulate the aseptic filling process using a microbiological growth…

Read More “Aseptic Process Simulation (Media Fill): Design, Execution and Interpretation” »

Media Fill Failure Investigations: Root Causes and CAPA That Satisfy Regulators Media Fill Failure Investigations: A Step-by-Step GMP Tutorial on Root Causes and CAPA In pharmaceutical manufacturing, sterility assurance is one of the most critical quality objectives, especially for sterile drug products. Media fill tests (MFT), also known as process simulations, are essential validation exercises…

Read More “Media Fill Failure Investigations: Root Causes and CAPA That Satisfy Regulators” »

Classifying Aseptic Interventions: Critical vs Non-Critical and How to Reduce Them A Step-by-Step Guide to Classifying Aseptic Interventions and Minimizing Contamination Risks Aseptic processing remains a cornerstone of sterile pharmaceutical product manufacturing, demanding uncompromising sterility assurance and stringent controls. Both regulatory authorities and quality systems emphasize the need to accurately classify and reduce aseptic interventions…

Read More “Classifying Aseptic Interventions: Critical vs Non-Critical and How to Reduce Them” »